Analysis of blood-derived circulating microvesicles for microRNA biomarkers of metastatic and nonmetastatic prostate cancer.
Freddie C. Hamdy(University of Oxford), Christine Kuslich(Phoenix (United States)), Traci Pawlowski(Illumina (United States)), Richard J. Bryant(University of Oxford), R L Vessella(University of Washington), Sierra J. Smith, Gemma Marsden(University of Oxford)
Cited by 0
Related Papers
Multiple newly identified loci associated with prostate cancer susceptibility
|Nature Genetics|2008|850
Changes in circulating microRNA levels associated with prostate cancer
|British Journal of Cancer|2012|717
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
|Cancer Cell|2021|453
Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
|Cancer Research|2009|328
Identification of genetic variants using bar-coded multiplexed sequencing
|Nature Methods|2008|305